Severe autoimmune polyendocrinopathy-candidiasis-ectodermal dystrophy in an adolescent girl with a novel AIRE mutation: Response to immunosuppressive therapy

Journal of Clinical Endocrinology and Metabolism

Volumn 84, Issue 3, 1999, Pages 844-852

  Ward, Leanne ^a   Paquette, Jean ^a   Seidman, Ernest ^a   Huot, Céline ^a   Alvarez, Fernando ^a   Crock, Patricia ^b   Delvin, Edgard ^a   Kämpe, Olle ^c   Deal, Cheri ^a  

^a UNIVERSITY OF MONTREAL   (Canada)

^b JOHN HUNTER CHILDREN S HOSPITAL   (Australia)

^c UPPSALA UNIVERSITY HOSPITAL   (Sweden)

Author keywords

[No Author keywords available]

Indexed keywords

ALLOPURINOL; CORTICOTROPIN; CYCLOSPORIN A; DNA; HYDROCORTISONE; MAGNESIUM; MAGNESIUM DERIVATIVE; METHOTREXATE; METHYLPREDNISOLONE; TRIACYLGLYCEROL LIPASE;

ADOLESCENT; ARTICLE; AUTOIMMUNE DISEASE; AUTOSOMAL RECESSIVE DISORDER; CANDIDIASIS; CASE REPORT; CHILD; CLINICAL FEATURE; CONTROLLED STUDY; DIABETES MELLITUS; ECTODERMAL DYSPLASIA; FOLLOW UP; GENE MUTATION; GENETIC ANALYSIS; HAPLOTYPE; HORMONE DEFICIENCY; HUMAN; HYPERURICEMIA; HYPOMAGNESEMIA; IMMUNOSUPPRESSIVE TREATMENT; INTRAVENOUS DRUG ADMINISTRATION; KERATOCONJUNCTIVITIS; MISSENSE MUTATION; ORAL DRUG ADMINISTRATION; PANCREAS INSUFFICIENCY; PRIORITY JOURNAL; STEROID THERAPY; SYNDROME; TREATMENT OUTCOME;

EID: 0032988183     PISSN: 0021972X     EISSN: None     Source Type: Journal    
DOI: 10.1210/jc.84.3.844     Document Type: Article

References (47)

1. Ahonen P, Myllärniemi S, Sipilä I, Perheentupa J. 1990 Clinical variation of autoimmune polyendocrinopathy-candidiasis-ectodermal dystrophy (APECED) in a series of 68 patients. N Engl J Med. 322:1829-1836.
2. Betterle C, Greggio NA, Volpato M. 1998 Autoimmune polyglandular syndrome type 1. J Clin Endocrinol Metab. 83:1049-1055.
3. Perheentupa J. 1996 Autoimmune polyendocrinopathy-candidiasis-ectodermal dystrophy (APECED). Horm Metab Res. 28:353-356.
4. Ahonen P. 1985 Autoimmune polyendocrinopathy-candidiasis-ectodermal dystrophy (APECED): autosomal recessive inheritance. Clin Genet. 27:535-542.
5. Des Marchais B, Bazin R. 1995 Keratitis associated with presumed polyendocrinopathy syndrome: treatment wtih fluorometholone and diclofenac sodium. Can J Ophthalmol. 30:380-384.
6. Aaltonen J, Björses P, Sandkuijl L, Perheentupa J, Peltonen L. 1997 An autosomal locus causing autoimune disease: autoimmune polyglandular disease type 1 assigned to chromosome 21. Nat Genet. 8:83-87.
7. Nagamine K, Peterson P, Scott H, et al. 1997 Positional cloning of the APECED gene. Nat Genet. 17:393-397.
8. The Finnish-German APECED Consortium. 1997 An autoimmune disease, APECED, caused by mutations in a novel gene featuring two PHD-type zinc-finger domains. Nat Genet. 17:399-403.
9. Scott H, Heino M, Peterson P, et al. 1998 Common mutations in autoimmune polyendocrinopathy-candidiasis-ectodermal dystrophy patients of different origins. Mol Endocrinol. 12:1112-1119.
10. Chen, QY, Lan MS, She JX, Maclaren N. 1998 The gene responsible for autoimmune polyglandular syndrome type 1 maps to chromosome 21q22.3 in US patients. J Autoimmun. 11:177-183.
11. Feutren G. 1992 The optimal use of cyclosporin A in autoimmune diseases. J Autoimmun. 5 Suppl A:183-195.
12. Seidman E, Lacaille F, Russo P, Galeano N, Murphy G, Roy C. 1990 Successful treatment of autoimmune enteropathy with cyclosporine. J Ped. 117:929-932.
13. Alvarez F, Bernard O, Homberg JC, Kreibich G. 1985 Anti-liver-kidney microsome antibody recognizes a 50,000 molecular weight protein of the endoplasmic reticulum. J Exp Med. 161:1231-1236.
14. Hadorn B, Zoppi G, Shmerling DH, Prader A, McIntyre I, Anderson CM. 1968 Quantitative assessment of exocrine pancreatic function in infants and children. J Ped. 73:39-50.
15. Allen HF, Jeffers BW, Klingensmith GJ, Chase HP. 1993 First-phase insulin release in normal children. J Ped. 123:733-738.
16. Greulich WW, Pyle SI. 1959 Radiographic atlas of skeletal development of the hand and wrist. Palo Alto, Calif: Stanford University Press.
17. Crock PA, Salvi M, Miller A, Wall J, Guyda H. 1993 Detection of anti-pituitary autoantibodies by immunoblotting. J Immunol Meth. 162:31-40.
18. Li Y, Song YH, Rais N, et al. 1996 Autoantibodies to the extracellular domain of the calcium sensing receptor in patients with acquired hypoparathyroidism. J Clin Invest. 97:910-914.
19. Colman PG, McNair P, Margetts H, et al. 1998 The Melbourne pre-diabetes study: prediction of type 1 diabetes mellitus using antibody and metabolic testing. Med J Aust. 169:81-84.
20. Rorsman F, Husebye E, Winqvist O, Björk E, Karlsson FA, Kämpe O. 1995 Aromatic-L-amino acid decarboxylase, a pyridoxal phosphate-dependent enzyme, is a β-cell autoantigen. Proc Natl Acad Sci USA. 92:8626-8629.
21. Ekwall O, Hedstrand H, Grimelius L, et al. 1998 Identification of tryphophan hydroxylase as an intestinal autoantigen. Lancet. 352:279-283.
22. Heubi JE, Partin JC, Schubert WK. 1983 Hypocalcemia and steatorrhea - clues to etiology. Dig Dis Sci. 28:124-128.
23. Scirè G, Magliocca FM, Cianfaroni S, et al. 1991 Autoimmune polyendocrine candidiasis syndrome with associated chronic diarrhea caused by intestinal infection and pancreas insufficiency. J Pediatr Gastroenterol Nutr. 13:224-227.
24. Bereket A, Lowenheim M, Blethen SL, Kane P, Wilson TA. 1995 Intestinal lymphangiectasia in a patient with autoimmune polyglandular disease type 1 and steatorrhea. J Clin Endocrinol Metab. 80:933-935.
25. Padeh S, Theodor R, Jonas A, Passwell JH. 1997 Severe malabsorption in autoimmune polyendocrinopathy-candidiasis-ectodermal dystrophy syndrome successfully treated with immunosuppression. Arch Dis Child. 76:532-534.
26. Kobayashi T, Hasegawa H, Kaneko E, Ichiyama A. 1991 Gastrointestinal serotonin: depletion due to tetrahydrobiopterin deficiency induced by 2,4-diamino-6-hydroxypyrimidine administration. J Pharmacol Exp Ther. 256:773-779.
27. Kirchgessner AL, Liu MT, Raymond JR, Gershon MD. 1996 Identification of cells that express 5-hydroxytryptamine 1A receptors in the nervous systems of the bowel and pancreas. J Comp Neurol. 364:439-455.
28. Pastore MR, Bazzigaluppi E, Bonfanti R, et al. 1998 Two-step islet autoantibody screening for risk assessment of type 1 diabetes in relatives. Diabetes Care. 21:1445-1450.
29. Tuomi T, Björses P, Falorni A, Partanen J, Perheentupa J, Lernmark A, Miettinen A. 1996 Antibodies to glutamic acid decarboxylase and insulin-dependent diabetes in patients with autoimmune polyendocrine syndrome type I. J Clin Endocrinol Metab. 81:1488-1494.
30. The Expert Committee. 1997 Report of the expert committee on the diagnosis and classification of diabetes mellitus. Diabetes Care. 20:1183-1197.
31. Eisenbarth GS, Wilson PW, Ward F, Buckley C, Lebovita H. 1979 The polyglandular failure syndrome: disease inheritance, HLA type and immune function. Ann Intern Med. 91:528-533.
32. Huang W, Connor E, Dela Rosa T, et al. 1996 Although DR3-DQB1 *0201 may be associated with multiple component diseases of the autoimmune polyglandular syndromes, the human leukocyte antigen DR4-DQB1 *0302 hapolytype is implicated only in β-cell autoimmunity. J Clin Endocrinol Metab. 81:2559-2563.
33. Ahonen P, Koskimies S, Lokki ML, Tiilikainen A, Perheentupa J. 1988 The expression of autoimmune polyglandular disease type 1 appears associated with several HLA-A antigens but not with HLA-DR. J Clin Endocrinol Metab. 66:1152-1157.
34. Bell GI, Horita S, Karam JH. 1984 A polymorphic locus near the human insulin gene is associated with insulin-dependent diabetes mellitus. Diabetes. 33:176-183.
35. Paquette J, Giannoukakis N, Polychronakos C, Vafiadis P, Deal C. 1998 The INS 5′ variable number of tandem repeats is associated with IGF-2 expression in humans. J Biol Chem. 273:14158-14164.
36. Thodou E, Asa SL, Kontogeorgos G, Kovacs K, Horvath E, Ezzat S. 1995 Clinical case seminar: lymphocytic hypophysitis: clinicopathological findings. J Clin Endocrinol Metab. 80:2302-2311.
37. Crock PA. 1998 Cytosolic autoantigens in lymphocytic hypophysitis. J Clin Endocrinol Metab. 83:609-618.
38. Ahmadi J, Meyers GS, Segall HD, Sharma OP, Hinton DR. 1995 Lymphocytic adenohypophysitis: contrast-enhanced MRI imaging in five cases. Radiology. 195:30-34.
39. Clemente MG, Obermayer-Straub P, Meloni A, Strassburg CP, Arangino V, Tukey RH, De Virgiliis S, Manns MP. 1997 Cytochrome P450 1A2 is a hepatic autoantigen in autoimmune polyglandular syndrome type 1. J Clin Endocrinol Metab. 82:1353-1361.
40. Goldstein NS, Rosenthal P, Sinatra F, Dehner LP. 1996 Liver disease in polyglandular autoimmune disease type one: clinicopathologic study of three patients and review of the literature. Ped Pathol Lab Med. 16:625-636.
41. Alvarez F, Ciocca M, Canero-Velasco C, et al. 1998 Short term cyclosporine induces a remission of autoimmune hepatitis in children. J Hepatol. In press.
42. Faulds D, Goa KL, Benfield P. 1993 Cyclosporin. A review of its pharmacodynamic and pharmacokinetic properties, and therapeutic use in immunoregulatory disorders. Drugs. 45:953-1040.
43. De Filippo G, Carel JC, Boitard C, Bougnères PF. 1996 Long-term results of early cyclosporin therapy in juvenile IDDM. Diabetes. 45:101-104.
44. Lippe BM, Kaplan SA, Golden MP, Hendricks SA, Scott ML. 1981 Carbohydrate tolerance and insulin receptor binding in children with hypopituitarism: responses after acute and chronic growth hormone administration. J Clin Endocrinol Metab. 53:507-513.
45. Bougnères PF, Artavia-Loria E, Ferre P, Chaussain JL, Job JC. 1985 Effects of hypopituitarism and growth hormone replacement therapy on the production and utilization of glucose in childhood. J Clin Endocrinol Metab. 61:1152-1157.
46. Kahn CR, Flier JS, Bar RS, et al. 1976 The syndromes of insulin resistance and acanthosis nigricans. Insulin-receptor disorders in man. N Engl J Med. 294:739-745.
47. Björses P, Aaltonen J, Vikman A, et al. 1996 Genetic homogeneity of autoimmune polyglandular disease type 1. Am J Hum Genet. 59:879-886.